機械学習ベースのQSARと分子モデリングによる小分子PRMT5阻害剤の構造的多様性と動的安定性の探求
Abida Khan1,2
1Center For Health Research, Northern Border University, 73213, Arar, Saudi Arabia. aqua_abkhan@yahoo.com.
Molecular diversity
|January 14, 2026
まとめ
研究者らは、計算手法を用いて、2つの潜在的なPRMT5阻害剤、CHEMBL4539612およびCHEMBL4577464を特定した。これらの化合物は、特にMTAP欠損がんに対する新規エピジェネティックがん治療法の開発に有望である。
さらに関連する動画
08:49Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
1.1K
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
3.6K
関連する概念動画
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Protein-protein Interfaces
14.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.4K
